MDxHealth S.A.
MXDHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $53 | $48 | $42 | $39 |
| % Growth | 10.7% | 14.4% | 8.4% | – |
| Cost of Goods Sold | $18 | $18 | $17 | $14 |
| Gross Profit | $35 | $30 | $25 | $25 |
| % Margin | 66% | 62% | 60.4% | 65.1% |
| R&D Expenses | $0 | $5 | $5 | $1 |
| G&A Expenses | $12 | $12 | $11 | $40 |
| SG&A Expenses | $32 | $32 | $32 | $28 |
| Sales & Mktg Exp. | $20 | $20 | $21 | -$12 |
| Other Operating Expenses | $7 | $3 | $2 | $7 |
| Operating Expenses | $39 | $40 | $39 | $36 |
| Operating Income | -$4 | -$11 | -$14 | -$11 |
| % Margin | -7.2% | -22.3% | -33.4% | -28% |
| Other Income/Exp. Net | -$12 | -$7 | -$6 | -$10 |
| Pre-Tax Income | -$16 | -$18 | -$20 | -$21 |
| Tax Expense | -$1 | $0 | $0 | $0 |
| Net Income | -$15 | -$18 | -$20 | -$21 |
| % Margin | -27.7% | -37.5% | -47.7% | -53.6% |
| EPS | -0.3 | -0.54 | -0.73 | -0.76 |
| % Growth | 44.4% | 26% | 3.9% | – |
| EPS Diluted | -0.3 | -0.38 | -0.73 | -0.76 |
| Weighted Avg Shares Out | 48 | 49 | 27 | 27 |
| Weighted Avg Shares Out Dil | 48 | 49 | 27 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $2 | $1 |
| Interest Expense | $13 | $7 | $5 | $10 |
| Depreciation & Amortization | $5 | $4 | $4 | $3 |
| EBITDA | $1 | -$6 | -$9 | -$17 |
| % Margin | 1.3% | -12.8% | -21.3% | -44% |